Last reviewed · How we verify
NK cell preparation — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
NK cell preparation (NK cell preparation) — Guangzhou Xiling Biotechnology Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| NK cell preparation TARGET | NK cell preparation | Guangzhou Xiling Biotechnology Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- NK cell preparation CI watch — RSS
- NK cell preparation CI watch — Atom
- NK cell preparation CI watch — JSON
- NK cell preparation alone — RSS
Cite this brief
Drug Landscape (2026). NK cell preparation — Competitive Intelligence Brief. https://druglandscape.com/ci/nk-cell-preparation. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab